Sponsored By

Making FDA a Friend, Not a Foe

During BIOMEDEVice Silicon Valley, a panel will discuss the various types of engagement that sponsors can have with FDA.

MDDI Staff

November 22, 2022

1 Min Read
IMG_2022-11-22-144114.jpg
Image courtesy of Araki Illustrations / Alamy Stock Photo

Engaging FDA can be a bit intimidating for some device makers. But it doesn’t have to be that way.  During BIOMEDevice Silicon Valley a panel will discuss the various types of engagement that sponsors can have with FDA, along with do's and don'ts for various types of interactions and the best times to engage.

It will cover the sponsor side and FDA side of the relationship.

Panelists Include:

  • Isabella Schmitt, Director of Regulatory Affairs at Proxima Clinical Research & Principal at M1MedTech

  • Pharoah Schnieber, COO at Boomerang Medical

  • Scott Trevino, Senior Vice President of Cybersecurity at Trimedx

 

 

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like